Login / Signup

CIQ, a positive allosteric modulator of GluN2C/D-containing N-methyl-d-aspartate receptors, rescues striatal synaptic plasticity deficit in a mouse model of Parkinson's disease.

Mona NouhiXiaoqun ZhangNing YaoKarima Chergui
Published in: CNS neuroscience & therapeutics (2017)
A positive allosteric modulator of GluN2C/D-containing NMDARs rescues LTP and forelimb-use asymmetry in a mouse model of PD. This study proposes GluN2D as a potential candidate for therapeutic intervention in PD.
Keyphrases
  • mouse model
  • small molecule
  • randomized controlled trial
  • parkinson disease
  • functional connectivity
  • risk assessment
  • human health
  • climate change
  • deep brain stimulation